NeurologyLive® Mind Moments®

147 Épisodes

1. 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development

   Publié: 03/05/2024
2. Special Episode: FDA Approval of Diazepam Buccal Film for Pediatric Seizures

   Publié: 01/05/2024
3. 113: Lessons Learned in Alzheimer Drug Development

   Publié: 19/04/2024
4. 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia

   Publié: 05/04/2024
5. Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy

   Publié: 29/03/2024
6. 111: Reviewing ACTRIMS 2024

   Publié: 22/03/2024
7. 110: Differential Diagnosis of Sleep Disorders and Hypersomnias

   Publié: 08/03/2024
8. 109: AB126, Exosomes, and Cerebroprotection for Stroke

   Publié: 23/02/2024
9. 108: Advancing the Genetic Pool of Parkinson Disease

   Publié: 09/02/2024
10. 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers

    Publié: 26/01/2024
11. 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis

    Publié: 12/01/2024
12. 105: Recapping Conversations in Neurology From 2023

    Publié: 29/12/2023
13. 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2

    Publié: 15/12/2023
14. 103: Advancing Epilepsy Care and Seizure Localization in Pediatrics

    Publié: 01/12/2023
15. 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease

    Publié: 17/11/2023
16. Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy

    Publié: 07/11/2023
17. 101: Ways to Enhance Neuromodulation in Parkinsonism

    Publié: 03/11/2023
18. Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis

    Publié: 23/10/2023
19. 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

    Publié: 20/10/2023
20. 99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy

    Publié: 05/10/2023